Penn study on fragile X syndrome uses fruitfly's point of view to identify new treatments
(University of Pennsylvania School of Medicine) The hormone insulin -- usually associated with diabetes -- is involved in the daily activity patterns and cognitive deficits in the fruitfly model of FXS. Results reveal a metabolic pathway that can be targeted by new and already approved drugs to treat fragile X patients.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Diabetes | Endocrinology | Fragile X Syndrome | Health | Hormones | Insulin | International Medicine & Public Health | Study | University of Pennsylvania